Parnax Lab Limited (BOM:506128)

Market Cap	1.46B
Revenue (ttm)	1.91B
Net Income (ttm)	108.27M
Shares Out	11.49M
EPS (ttm)	9.43
PE Ratio	13.43
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	6,868
Average Volume	6,525
Open	135.00
Previous Close	133.00
Day's Range	129.15 - 137.00
52-Week Range	81.00 - 193.50
Beta	0.46
RSI	54.58
Earnings Date	Aug 14, 2025

About Parnax Lab

Parnax Lab Limited manufactures and sells pharmaceutical formulations in India and internationally. The company offers pharmaceutical products in the form of liquids, ointments, gels, creams, tablets, and capsules; and medicinal products. It provides cosmetic products; herbal; and nutraceutical products. The company was formerly known as Krishna-Deep Trade & Investments Limited and changed its name to Parnax Lab Limited in April 2012. The company was incorporated in 1982 and is headquartered in Mumbai, India.

• Industry: Pharmaceutical Preparations
• Founded: 1982
• Employees: 12
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 506128

Financial Performance

In 2024, Parnax Lab's revenue was 1.88 billion, a decrease of -0.56% compared to the previous year's 1.89 billion. Earnings were 115.19 million, an increase of 19.87%.